Open AccessDrug Therapy for Unexplained Dyspnea in Post–COVID-19 Fatigue Syndrome: Empagliflozin and Sildenafil
Author(s) -
Peter Manu
Publication year - 2022
Publication title -
american journal of therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.349
H-Index - 62
eISSN - 1536-3686
pISSN - 1075-2765
DOI - 10.1097/mjt.0000000000001483
Subject(s) - medicine , exercise intolerance , heart failure , heart failure with preserved ejection fraction , cardiology , myopathy , pulmonary hypertension , ejection fraction , intensive care medicine